In: Clinical Research in Cardiology, 2015, vol. 104, no. 1, p. 51-58
|
In: Basic Research in Cardiology, 2015, vol. 110, no. 1, p. 1-17
|
In: The International Journal of Cardiovascular Imaging, 2015, vol. 31, no. 5, p. 915-926
|
In: Clinical Chemistry and Laboratory Medicine (CCLM), 2017, vol. 55, no. 7, p. 1034-1042
|
In: European Radiology, 2015, vol. 25, no. 7, p. 2067-2073
|
In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1213-1220
|
In: Journal of General Internal Medicine, 2015, vol. 30, no. 1, p. 17-24
|
In: Journal of Perinatal Medicine, 2017, vol. 45, no. 7, p. 829-835
|
In: Catheterization and Cardiovascular Interventions, 2019, p. ccd.28376
To evaluate the safety and efficacy outcomes after primary percutaneous coronary intervention (pPCI) with second‐generation Resolute™ zotarolimus‐eluting stent (R‐ ZES) in patients enrolled in the DAPT‐STEMI Trial (NCT01459627).Background: R‐ ZES is one of the most used drug eluting stents worldwide. To date, the safety and efficacy data of this stent in setting of STEMI is...
|
In: Heart Failure Reviews, 2014, vol. 19, no. 6, p. 815-824
|